Icon
+91 94997 68112
Login Register

Procysbi - (25, 75 mg; Capsule delayed release)

Cysteamine Bitartrate Horizon Pharma
25, 75 mg; Capsule delayed release
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None None
PROCYSBI is a cystine-depleting agent indicated for the treatment of nephropathic cystinosis in adults and pediatric patients 1 year of age and older.
Yes
*** *********** ******* ** *** **** *** ****. ***** ** ***. ***** ***** * **** ** ** *** ******* *** *** *********. ** ****** **** **** ***** ****** ** *** ****. ** **** **, **** ***** *** ** ****** *** *** , ’*** ’, *** ’, *** *** ’***. ***** *** ** * ******* *** ********** ********* ** *** ********* ** *** *, ****. ** *** *** ******'* (*****://**.*******************.***/******-*****/********-****-****-****-************) **** **. ** ***** *** ***** ****** ** ***** **, ****.
Procysbi Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11
***** ******* ******* ******* ******* ******* *** *** *** ******* *** ***
**** **** ** ***** **, **** **** ** ***** **, **** **** ** ***** **, **** **** ** ***** **, **** **** ** ***** **, **** *** ********* *** ********* *** ********* **** ** ***** **, **** *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ********* *** **, **** *** ********* / ******* **** ** ***** **, ****
**** ** \ ** **** **, **** ******* **** ***** **** ****
  1. *** **, **** : ***** ******** ******* ****** ***** **'* **** ** ****** ** *** *******.
  2. *** **, **** : ******* ***** * **** ******* ***** ** *** *******.
  3. *** **, **** : ***** *** ** ****** *** *** , ’*** ’, *** ’, *** *** ’***.
  4. *** *, **** : ********** ******* ***** ** ********* ** *** ********* *******.
  5. *** *, **** : ******* ******* **** ***** ** *** **** ** *** ******* ** ****. ***** ** ***** ** ********** ***** *** ***** ****** ** ***** **, ****.
  6. *** **, **** : **** ******** ******* ***** *** **** ** ******.
  7. *** **, **** : ******* **** **** ** ******* '***, '***, '***, '***, '*** *** '***.

Procysbi - (75 mg/Packet and 300 mg/Packet ; Delayed-release Granules)

Cysteamine Bitartrate Horizon Pharma
75 mg/Packet and 300 mg/Packet ; Delayed-release Granules
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None None
PROCYSBI is a cystine-depleting agent indicated for the treatment of nephropathic cystinosis in adults and pediatric patients 1 year of age and older.
Yes
Procysbi Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11 Patent 12
**** **** ** ***** **, **** **** ** ***** **, **** **** ** ***** **, **** **** ** ***** **, **** **** ** ***** **, **** *** ********* *** ********* *** ********* **** ** ***** **, **** *** ********* *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** / ********* **** **, **** ******* **** *** ****** **** ****
  1. *** **, **** : * **** ** *** ***** *** ***** ** * *** *******.
  2. *** *, **** : **** ******** ******* ***** *** **** ** ******.
  3. *** **, **** : ******* **** **** ** ******* '***, '***, '***, '***, '*** *** '***.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.